In a criminal sentencing decision following trial convictions under ss. 5(2) and 7(1) of the Controlled Drugs and Substances Act, the court addressed large-scale production and possession for the purpose of trafficking in MDMA, methamphetamine, and ketamine from a clandestine laboratory.
The evidence established a high-capacity operation with significant public-safety and health risks, including deceptive marketing of tablets containing highly addictive methamphetamine.
The court treated denunciation and general deterrence as paramount, relying on comparator jurisprudence and the seriousness of domestic synthetic-drug production.
Applying aggravating and mitigating factors individually, the court imposed lengthy penitentiary terms on all three offenders, with concurrent sentences on each count and ancillary DNA and firearms-prohibition orders.
